Candida auris detected across 27 states: key facts for the public

As of the week ending July 25, 2026, 3,437 cases of Candida auris have been identified across 27 states (California leading with 873, followed by Texas with 433 and Tennessee with 283), and the number of cases continues to rise each year, though the rate of increase has slowed since 2022. C. auris is a drug‑resistant yeast that can cause infections ranging from skin infections to life-threatening bloodstream infections in very ill patients in healthcare settings, and it can persist on surfaces. Many strains are resistant to fluconazole, with some showing resistance to amphotericin B and echinocandins, and the mortality rate is estimated between 30% and 60%. Those most at risk include immunocompromised individuals and patients with invasive devices in hospitals or nursing homes.